Merus’ $460m Upsized Follow-On Offering of Common Shares

Latham & Watkins and NautaDutilh advised Merus on the offering.Merus N.V., an oncology company in the clinical stage, successfully raised an estimated USD 460 million in…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Georgio Naffaa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here